Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Finding host targets for HIV therapy

Nature Genetics volume 49, pages 175–176 (2017)Cite this article

Subjects

A CRISPR screen conducted in a CD4+ T cell leukemia line has identified host factors required for HIV infection but dispensable for cellular survival. The results highlight sulfation on the HIV co-receptor CCR5 and cellular aggregation as potential targets for therapeutic intervention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Sulfation of CCR5 and cell–cell adhesion are host processes crucial for HIV entry and spread.

Marina Corral Spence/Springer Nature

References

  1. Friedrich, B.M. et al. Virus Res. 161, 101–114 (2011).

    Article  CAS  Google Scholar 

  2. Hütter, G. et al. N. Engl. J. Med. 360, 692–698 (2009).

    Article  Google Scholar 

  3. Tebas, P. et al. N. Engl. J. Med. 370, 901–910 (2014).

    Article  CAS  Google Scholar 

  4. Park, R.J. et al. Nat. Genet. 49, 193–203 (2017).

    Article  CAS  Google Scholar 

  5. Bushman, F.D. et al. PLoS Pathog. 5, e1000437 (2009).

    Article  Google Scholar 

  6. Zhu, J. et al. Cell Rep. 9, 752–766 (2014).

    Article  CAS  Google Scholar 

  7. Wang, T. et al. Science 350, 1096–1101 (2015).

    Article  CAS  Google Scholar 

  8. Kamiyama, S. et al. J. Biol. Chem. 278, 25958–25963 (2003).

    Article  CAS  Google Scholar 

  9. Seibert, C., Cadene, M., Sanfiz, A., Chait, B.T. & Sakmar, T.P. Proc. Natl. Acad. Sci. USA 99, 11031–11036 (2002).

    Article  CAS  Google Scholar 

  10. Agosto, L.M., Uchil, P.D. & Mothes, W. Trends Microbiol. 23, 289–295 (2015).

    Article  CAS  Google Scholar 

  11. Gulick, R.M. et al. N. Engl. J. Med. 359, 1429–1441 (2008).

    Article  CAS  Google Scholar 

  12. Sasaki, N. et al. Mol. Endocrinol. 21, 1713–1721 (2007).

    Article  CAS  Google Scholar 

  13. Clément, A. et al. PLoS Genet. 4, e1000136 (2008).

    Article  Google Scholar 

  14. Ghosh, S., Chackerian, A.A., Parker, C.M., Ballantyne, C.M. & Behar, S.M. J. Immunol. 176, 4914–4922 (2006).

    Article  CAS  Google Scholar 

  15. Besnard, E. et al. Cell Host Microbe 20, 785–797 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amita Gupta and Michael C. Bassik are in the Departments of Genetics and Chemistry, C. Kimberly Tsui, Engineering and Medicine for Human Health (ChEM-H), Stanford University, Stanford, California, USA.,

    C Kimberly Tsui, Amita Gupta & Michael C Bassik

Authors
  1. C Kimberly Tsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amita Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael C Bassik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael C Bassik.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsui, C., Gupta, A. & Bassik, M. Finding host targets for HIV therapy. Nat Genet 49, 175–176 (2017). https://doi.org/10.1038/ng.3777

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3777

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research